ALGREEN |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0002 EUR | 0.00% |
|
0.00% | -94.29% |
| Jan. 31 | Algreen Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
| 2023 | Algreen Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
Valuation
| Fiscal Period: März | 2018 | 2019 | 2020 | 2022 | 2023 |
|---|---|---|---|---|---|
| Capitalization 1 | 3.093 | 4.072 | 9.669 | 1.899 | 0.6197 |
| Enterprise Value (EV) 1 | 3.08 | 4.755 | 9.475 | 5.538 | 6.958 |
| P/E ratio | -3.87 x | - | -8.03 x | - | -0.06 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 3.25 x | 2.98 x | 4.59 x | 0.91 x | 0.09 x |
| EV / Revenue | 3.24 x | 3.47 x | 4.49 x | 2.64 x | 1.01 x |
| EV / EBITDA | -2.58 x | -3.21 x | -7.17 x | - | -5.83 x |
| EV / FCF | - | - | - | - | -901,749 x |
| FCF Yield | - | - | - | - | -0% |
| Price to Book | 6.86 x | - | 9.26 x | -2.65 x | 0.1 x |
| Nbr of stocks (in thousands) | 51.5 | 79.2 | 92 | 144 | 645 |
| Reference price 2 | 60.00 | 51.43 | 105.1 | 13.14 | 0.9600 |
| Announcement Date | 6/6/19 | 5/21/21 | 5/21/21 | 7/30/22 | 7/28/23 |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: März | 2018 | 2019 | 2020 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net sales 1 | 0.9518 | 1.369 | 2.109 | 2.095 | 6.917 |
| EBITDA 1 | -1.194 | -1.483 | -1.322 | - | -1.193 |
| EBIT 1 | -1.326 | -1.595 | -1.461 | -1.354 | -1.399 |
| Operating Margin | -139.32% | -116.53% | -69.28% | -64.62% | -20.23% |
| Earnings before Tax (EBT) 1 | -1.425 | -1.791 | -1.597 | -1.971 | -11.21 |
| Net income 1 | -1.425 | -1.791 | -1.597 | -1.971 | -11.13 |
| Net margin | -149.69% | -130.83% | -75.76% | -94.07% | -160.91% |
| EPS 2 | -15.49 | - | -13.09 | - | -17.24 |
| Free Cash Flow | - | - | - | - | -7.716 |
| FCF margin | - | - | - | - | -111.55% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 6/6/19 | 5/21/21 | 5/21/21 | 7/30/22 | 7/28/23 |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net Debt 1 | - | 0.68 | - | 3.64 | 6.34 |
| Net Cash position 1 | 0.01 | - | 0.19 | - | - |
| Leverage (Debt/EBITDA) | - | -0.4605 x | - | - | -5.313 x |
| Free Cash Flow | - | - | - | - | -7.72 |
| ROE (net income / shareholders' equity) | -144% | -579% | -266% | - | -419% |
| ROA (Net income/ Total Assets) | -35.1% | -40.4% | -30.1% | - | -9.05% |
| Assets 1 | 4.059 | 4.43 | 5.304 | - | 122.9 |
| Book Value Per Share 2 | 8.750 | - | 11.30 | -4.950 | 9.640 |
| Cash Flow per Share 2 | 15.60 | - | 14.00 | 2.300 | 1.060 |
| Capex | - | - | - | - | 0.08 |
| Capex / Sales | - | - | - | - | 1.13% |
| Announcement Date | 6/6/19 | 5/21/21 | 5/21/21 | 7/30/22 | 7/28/23 |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -94.29% | 138 | |
| +14.48% | 485B | |
| +21.40% | 40.05B | |
| +5.39% | 38.37B | |
| +18.78% | 34B | |
| +7.63% | 28.47B | |
| -15.08% | 25.16B | |
| -0.55% | 25.08B | |
| +11.96% | 17.99B | |
| +4.35% | 17.88B |
- Stock Market
- Equities
- ALGRE Stock
- Financials Algreen
